company background image
COLO B logo

Coloplast CPSE:COLO B Stock Report

Last Price

DKK 786.20

Market Cap

DKK 177.0b

7D

-0.9%

1Y

1.8%

Updated

30 Dec, 2024

Data

Company Financials +

Coloplast A/S

CPSE:COLO B Stock Report

Market Cap: DKK 177.0b

COLO B Stock Overview

Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. More details

COLO B fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance3/6
Financial Health2/6
Dividends3/6

Rewards

Trading at 47.5% below our estimate of its fair value

Earnings are forecast to grow 11.76% per year

Earnings have grown 4.9% per year over the past 5 years

Risk Analysis

Debt is not well covered by operating cash flow

Dividend of 2.8% is not well covered by earnings or free cash flows


My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
Analyst Price Target
Consensus Narrative from 21 Analysts

Kerecis Acquisition To Transform Advanced Wound Care Segment

Key Takeaways Improved operational efficiency and strategic expansions are expected to enhance net margins and earnings over the long term. Strategic acquisitions and growth in niche markets are projected to boost revenue and transform key business segments.
View narrative
DKK 924.43
FV
15.0% undervalued intrinsic discount
8.36%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative

Coloplast A/S Competitors

Demant

CPSE:DEMANT

DKK 57.5b

Ambu

CPSE:AMBU B

DKK 27.7b

Embla Medical hf

CPSE:EMBLA

DKK 15.2b

Cooper Companies

NasdaqGS:COO

US$18.4b

Price History & Performance

Summary of share price highs, lows and changes for Coloplast
Historical stock prices
Current Share PriceDKK 786.20
52 Week HighDKK 977.60
52 Week LowDKK 757.80
Beta0.33
1 Month Change-11.60%
3 Month Change-10.29%
1 Year Change1.84%
3 Year Change-31.13%
5 Year Change-4.15%
Change since IPO6,052.87%

Recent News & Updates

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Dec 04
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Should Shareholders Have Second Thoughts About A Pay Rise For Coloplast A/S' (CPH:COLO B) CEO This Year?

Nov 29
Should Shareholders Have Second Thoughts About A Pay Rise For Coloplast A/S' (CPH:COLO B) CEO This Year?

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 13
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Recent updates

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Dec 04
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Should Shareholders Have Second Thoughts About A Pay Rise For Coloplast A/S' (CPH:COLO B) CEO This Year?

Nov 29
Should Shareholders Have Second Thoughts About A Pay Rise For Coloplast A/S' (CPH:COLO B) CEO This Year?

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 13
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Nov 08
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 23
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Aug 22
Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

Jul 17
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jun 29
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Shareholder Returns

COLO BDK Medical EquipmentDK Market
7D-0.9%0.5%1.8%
1Y1.8%0.8%-3.7%

Return vs Industry: COLO B exceeded the Danish Medical Equipment industry which returned 0.8% over the past year.

Return vs Market: COLO B exceeded the Danish Market which returned -3.7% over the past year.

Price Volatility

Is COLO B's price volatile compared to industry and market?
COLO B volatility
COLO B Average Weekly Movement3.2%
Medical Equipment Industry Average Movement3.6%
Market Average Movement4.4%
10% most volatile stocks in DK Market10.3%
10% least volatile stocks in DK Market2.9%

Stable Share Price: COLO B has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: COLO B's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195416,639Kristian Villumsenwww.coloplast.com

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Coloplast A/S Fundamentals Summary

How do Coloplast's earnings and revenue compare to its market cap?
COLO B fundamental statistics
Market capDKK 177.00b
Earnings (TTM)DKK 5.05b
Revenue (TTM)DKK 27.03b

35.0x

P/E Ratio

6.5x

P/S Ratio

Is COLO B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
COLO B income statement (TTM)
RevenueDKK 27.03b
Cost of RevenueDKK 8.76b
Gross ProfitDKK 18.27b
Other ExpensesDKK 13.22b
EarningsDKK 5.05b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 04, 2025

Earnings per share (EPS)22.44
Gross Margin67.59%
Net Profit Margin18.69%
Debt/Equity Ratio120.6%

How did COLO B perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

98%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 22:11
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Coloplast A/S is covered by 49 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Kamla SinghAlphaValue
Robert BateBarclays